PortfoliosLab logo

Cullinan Oncology, Inc. (CGEM)

Equity · Currency in USD · Last updated Jul 2, 2022

Company Info

ISINUS2300311063
CUSIP230031106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$12.93
Year Range$7.31 - $29.68
EMA (50)$11.97
EMA (200)$16.26
Average Volume$702.22K
Market Capitalization$579.04M

CGEMShare Price Chart


Chart placeholderClick Calculate to get results

CGEMPerformance

The chart shows the growth of $10,000 invested in Cullinan Oncology, Inc. on Jan 11, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,323 for a total return of roughly -56.77%. All prices are adjusted for splits and dividends.


CGEM (Cullinan Oncology, Inc.)
Benchmark (^GSPC)

CGEMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M20.95%-7.43%
6M-17.64%-19.95%
YTD-16.20%-19.74%
1Y-49.79%-10.99%
5Y-43.34%0.01%
10Y-43.34%0.01%

CGEMMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CGEMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Cullinan Oncology, Inc. Sharpe ratio is -0.68. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CGEM (Cullinan Oncology, Inc.)
Benchmark (^GSPC)

CGEMDividend History


Cullinan Oncology, Inc. doesn't pay dividends

CGEMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CGEM (Cullinan Oncology, Inc.)
Benchmark (^GSPC)

CGEMWorst Drawdowns

The table below shows the maximum drawdowns of the Cullinan Oncology, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Cullinan Oncology, Inc. is 86.32%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.32%Mar 11, 2021296May 11, 2022
-17.29%Mar 3, 20212Mar 4, 20214Mar 10, 20216
-12.59%Jan 26, 20217Feb 3, 20216Feb 11, 202113
-11.61%Feb 22, 20215Feb 26, 20211Mar 1, 20216
-9.65%Jan 15, 20212Jan 19, 20211Jan 20, 20213
-6.39%Jan 11, 20211Jan 11, 20212Jan 13, 20213
-0.23%Feb 18, 20211Feb 18, 20211Feb 19, 20212

CGEMVolatility Chart

Current Cullinan Oncology, Inc. volatility is 46.00%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CGEM (Cullinan Oncology, Inc.)
Benchmark (^GSPC)

Portfolios with Cullinan Oncology, Inc.


Loading data...